EVANSTON, Ill., Dec. 05, 2018 (GLOBE NEWSWIRE) — Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the […]
Press Release Companies enter long-term technology partnership to increase network speed and capacity and enhance mobile and fixed broadband service […]